Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mechanism of action and pharmacology studies with DTIC (NSC-45388).

× No keyword cloud information.

16 in total

1. Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier.

Authors: Musallam Almoussalam; Huijun Zhu
Journal: J Vis Exp Date: 2016-04-26 Impact factor: 1.355

Review 2. Antineoplastic drugs in 1990. A review (Part II).

Authors: D J Black; R B Livingston
Journal: Drugs Date: 1990-05 Impact factor: 9.546

3. Pharmacokinetics of dacarbazine (DTIC) in pregnancy.

Authors: Ira Kantrowitz-Gordon; Karen Hays; Olumide Kayode; Aditya R Kumar; Henry G Kaplan; Joel M Reid; Stephanie L Safgren; Matthew M Ames; Thomas R Easterling; Mary F Hebert
Journal: Cancer Chemother Pharmacol Date: 2018-01-05 Impact factor: 3.333

Review 4. Intestinal and liver toxicity of antineoplastic drugs.

Authors: G B McDonald; N Tirumali
Journal: West J Med Date: 1984-02

Review 5. Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors.

Authors: Nitya Raj; Diane Reidy-Lagunes
Journal: Hematol Oncol Clin North Am Date: 2015-10-23 Impact factor: 3.722

6. Application of a microsomal drug activation system in a human tumor cloning assay.

Authors: H R Metelmann; D D Von Hoff
Journal: Invest New Drugs Date: 1983 Impact factor: 3.850

7. Establishment, characterization, and response to cytotoxic and radiation treatment of three human melanoma cell lines.

Authors: A Courdi; J Gioanni; C M Lalanne; J L Fischel; M Schneider; F Ettore; J C Lambert
Journal: In Vitro Date: 1983-06

8. Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules.

Authors: H Breithaupt; A Dammann; K Aigner
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

9. Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma.

Authors: P J Frosch; B M Czarnetzki; E Macher; E Grundmann; I Gottschalk
Journal: J Cancer Res Clin Oncol Date: 1979 Impact factor: 4.553

10. A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors.

Authors: D R Adkins; R Irvin; J Kuhn; D H Boldt; G D Roodman; D Salzman; C Freytes; D D Von Hoff; C F LeMaistre
Journal: Invest New Drugs Date: 1993 May-Aug Impact factor: 3.850